FOR HEALTHCARE PROFESSIONALS
Not a Booster. A Regulator.
FOR HEALTHCARE PROFESSIONALS
Not a Booster. A Regulator.
Most immune supplements work by stimulating the immune system broadly — pushing harder, amplifying activity, adding fuel. That approach has its place. But it doesn't address what actually declines as we age: the thymus gland's ability to produce and mature functional T-cells.
Thymic Protein A (TPA) works upstream. It is the signaling protein your thymus produces naturally — the one that binds to immature CD4+ T-cells and initiates their maturation into functional immune responders. When that signal declines (as it does for virtually everyone over 40), the entire downstream immune cascade loses precision.
TPA doesn't stimulate. It restores the signal — helping the immune system respond appropriately: stronger when threatened, calmer when overactive.
That's immune modulation. And it's the only supplement of its kind.
35 Years. One Protein. One Scientist.
Thymic Protein A was discovered by Dr. Terry Beardsley, PhD — an immunologist whose foundational research was published in the Proceedings of the National Academy of Sciences in 1983, communicated by Nobel laureate Nathan O. Kaplan.
TPA is a complete, intact glycoprotein of approximately 500 amino acids (50 kDa). It is produced by stromal epithelial cells of the thymus gland, and its function is highly specific: binding CD4 receptors on immature progenitor T-cells to initiate their maturation into functional CD4+ helper T-cells.
This maturation cascade is upstream of nearly every measurable immune response. CD4+ cells regulate cytokine secretion (IL-2, IFN-γ), activate CD8+ cytotoxic cells, and differentiate into memory, regulatory, and helper subsets. The amplification effect is substantial — which is why TPA is active at microgram doses.
TPA is distinct from thymic extracts, thymosin fractions, and peptide supplements. It is a single, purified, intact protein with a verified mechanism of action. Its amino acid sequence shares no homology with any known cytokine, including IL-1, IL-2, IL-3, IL-4, IL-6, IL-7, or G-CSF.
Dr. Beardsley is the only person in the world who manufactures TPA. It is produced at his Murrieta, California laboratory under his direct supervision. There is one source. There is no generic.
Clinical Evidence
Human Studies. Peer-Reviewed. Cited.
TPA's clinical record spans human trials, a USDA-licensed injectable form used in veterinary medicine, and 35+ years of practitioner use. Below are the key published studies most relevant to clinical practice.
What Practitioners are Saying
Trusted by Physicians for Over Three Decades
Clinical Applications
Where Practitioners Are Using TPA
TPA is an immune modulator — which means it is appropriate for both underactive and overactive immune presentations. No known drug interactions. Safe to use alongside any existing protocol.
One Protein. Three Formats. Built for Clinical Flexibility.
All Humanset products deliver the same purified, intact Thymic Protein A. Format choice depends on patient preference and delivery method.
TPA Powder Packets — 4 mcg | Sublingual
Best for fastest absorption and acute support protocols. Pour under tongue, hold 60 seconds.
TPA Capsules — 4 mcg | Delayed-Release
Best for daily convenience. Capsule bypasses stomach and absorbs in the intestine.
TPA Tablets — 1 mcg | Sublingual
Best for daily maintenance and flexible lower-dose protocols. Dissolves under tongue.
Maintenance: 1 serving/day (4mcg product) or 1–4 tablets/day (1mcg)
Active support: 2–3 servings/day, as often as every 3–4 hours
Food timing: At least 30 min before or 60 min after food
Consistency: Minimum 30 days recommended for chronic presentations
No known drug interactions. No known contraindications. Safe for long-term use.
Non-GMO. Gluten-free. Dairy-free. Made in the USA.
Take Action
Three Ways to Get Started With Humanset